183 related articles for article (PubMed ID: 27932423)
1. Integrated genomic analysis of survival outliers in glioblastoma.
Peng S; Dhruv H; Armstrong B; Salhia B; Legendre C; Kiefer J; Parks J; Virk S; Sloan AE; Ostrom QT; Barnholtz-Sloan JS; Tran NL; Berens ME
Neuro Oncol; 2017 Jun; 19(6):833-844. PubMed ID: 27932423
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling of long-term IDH-wildtype glioblastoma survivors.
Burgenske DM; Yang J; Decker PA; Kollmeyer TM; Kosel ML; Mladek AC; Caron AA; Vaubel RA; Gupta SK; Kitange GJ; Sicotte H; Youland RS; Remonde D; Voss JS; Fritcher EGB; Kolsky KL; Ida CM; Meyer FB; Lachance DH; Parney IJ; Kipp BR; Giannini C; Sulman EP; Jenkins RB; Eckel-Passow JE; Sarkaria JN
Neuro Oncol; 2019 Nov; 21(11):1458-1469. PubMed ID: 31346613
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
Michaelsen SR; Urup T; Olsen LR; Broholm H; Lassen U; Poulsen HS
J Neurooncol; 2018 May; 137(3):533-542. PubMed ID: 29305787
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiles of long- and short-term glioblastoma survivors.
Shinawi T; Hill VK; Krex D; Schackert G; Gentle D; Morris MR; Wei W; Cruickshank G; Maher ER; Latif F
Epigenetics; 2013 Feb; 8(2):149-56. PubMed ID: 23291739
[TBL] [Abstract][Full Text] [Related]
5. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
[TBL] [Abstract][Full Text] [Related]
6. LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.
Mock A; Geisenberger C; Orlik C; Warta R; Schwager C; Jungk C; Dutruel C; Geiselhart L; Weichenhan D; Zucknick M; Nied AK; Friauf S; Exner J; Capper D; Hartmann C; Lahrmann B; Grabe N; Debus J; von Deimling A; Popanda O; Plass C; Unterberg A; Abdollahi A; Schmezer P; Herold-Mende C
Int J Cancer; 2016 Jul; 139(2):424-32. PubMed ID: 26934681
[TBL] [Abstract][Full Text] [Related]
7. Predictive Model to Identify the Long Time Survivor in Patients with Glioblastoma: A Cohort Study Integrating Machine Learning Algorithms.
Yang XL; Zeng Z; Wang C; Sheng YL; Wang GY; Zhang FQ; Lian X
J Mol Neurosci; 2024 Apr; 74(2):48. PubMed ID: 38662286
[TBL] [Abstract][Full Text] [Related]
8. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
Lu J; Cowperthwaite MC; Burnett MG; Shpak M
PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
[TBL] [Abstract][Full Text] [Related]
9. Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma.
Beig N; Patel J; Prasanna P; Hill V; Gupta A; Correa R; Bera K; Singh S; Partovi S; Varadan V; Ahluwalia M; Madabhushi A; Tiwari P
Sci Rep; 2018 Jan; 8(1):7. PubMed ID: 29311558
[TBL] [Abstract][Full Text] [Related]
10. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.
Cho HJ; Zhao J; Jung SW; Ladewig E; Kong DS; Suh YL; Lee Y; Kim D; Ahn SH; Bordyuh M; Kang HJ; Sa JK; Seo YJ; Kim ST; Lim DH; Dho YS; Lee JI; Seol HJ; Choi JW; Park WY; Park CK; Rabadan R; Nam DH
Neuro Oncol; 2019 Jan; 21(1):47-58. PubMed ID: 30085274
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide methylation profiling reveals new biomarkers for prognosis prediction of glioblastoma.
Ma J; Hou X; Li M; Ren H; Fang S; Wang X; He C
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C212-5. PubMed ID: 26506879
[TBL] [Abstract][Full Text] [Related]
12. Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma.
Ofek P; Yeini E; Arad G; Danilevsky A; Pozzi S; Luna CB; Dangoor SI; Grossman R; Ram Z; Shomron N; Brem H; Hyde TM; Geiger T; Satchi-Fainaro R
Int J Cancer; 2023 Aug; 153(3):654-668. PubMed ID: 37141410
[TBL] [Abstract][Full Text] [Related]
13. Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors.
Barbus S; Tews B; Karra D; Hahn M; Radlwimmer B; Delhomme N; Hartmann C; Felsberg J; Krex D; Schackert G; Martinez R; Reifenberger G; Lichter P
J Natl Cancer Inst; 2011 Apr; 103(7):598-606. PubMed ID: 21346226
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain.
Geisenberger C; Mock A; Warta R; Rapp C; Schwager C; Korshunov A; Nied AK; Capper D; Brors B; Jungk C; Jones D; Collins VP; Ichimura K; Bäcklund LM; Schnabel E; Mittelbron M; Lahrmann B; Zheng S; Verhaak RG; Grabe N; Pfister SM; Hartmann C; von Deimling A; Debus J; Unterberg A; Abdollahi A; Herold-Mende C
Acta Neuropathol; 2015 Sep; 130(3):419-34. PubMed ID: 25931051
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive molecular characterization of long-term glioblastoma survivors.
Xu H; Chen X; Sun Y; Hu X; Zhang X; Wang Y; Tang Q; Zhu Q; Song K; Chen H; Sheng X; Yao Y; Zhuang D; Chen L; Mao Y; Qin Z
Cancer Lett; 2024 May; 593():216938. PubMed ID: 38734160
[TBL] [Abstract][Full Text] [Related]
16. Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastoma.
van der Meulen M; Ramos RC; Voisin MR; Patil V; Wei Q; Singh O; Climans SA; Kalidindi N; Or R; Aldape K; Diamandis P; Munoz DG; Zadeh G; Mason WP
Neurooncol Adv; 2024; 6(1):vdae001. PubMed ID: 38312227
[TBL] [Abstract][Full Text] [Related]
17. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus.
Shukla S; Pia Patric IR; Thinagararjan S; Srinivasan S; Mondal B; Hegde AS; Chandramouli BA; Santosh V; Arivazhagan A; Somasundaram K
Cancer Res; 2013 Nov; 73(22):6563-73. PubMed ID: 24078801
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
Lehrer S; Rheinstein PH; Rosenzweig KE
Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma.
Zhang W; Yan W; You G; Bao Z; Wang Y; Liu Y; You Y; Jiang T
Cancer Lett; 2013 Jan; 328(1):120-5. PubMed ID: 22960273
[TBL] [Abstract][Full Text] [Related]
20. Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.
Burton EC; Lamborn KR; Feuerstein BG; Prados M; Scott J; Forsyth P; Passe S; Jenkins RB; Aldape KD
Cancer Res; 2002 Nov; 62(21):6205-10. PubMed ID: 12414648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
